Yemaachi Biotechnology

Diversifying precision cancer diagnostics and treatments

Y CombinatorSummer 2021ActiveHealthcareDiagnosticsBiotechDiagnosticsTherapeutics

What they do

Problem

Precision cancer diagnostics and treatments are less accurate and less accessible for African populations due to underrepresentation in genomic and clinical datasets.

Solution

The company collects and sequences cancer samples across Africa to build a clinical and molecular knowledgebase that improves existing diagnostic tests and enables discovery of new diagnostics and therapeutics.

Who it's for

Diagnostic and biotech/pharma companies, as well as clinical researchers and healthcare providers focused on cancer care.

Founders

Yaw Bediako

Founder

With extensive expertise in cellular and molecular immunology, Yaw has a keen interest in immune function as relates to non-communicable diseases among African populations. Yaw is very active in efforts to promote the development of a sustainable research ecosystem across sub-Saharan Africa. He is one of 5 scientists selected in the inaugural round of the prestigious Crick Africa Network Fellowship, an affiliate member of the African Academy of Sciences and a fellow of the Ghana Young Academy.

LinkedIn · X

Yaw Attua-Afari

Founder

Finance and Investment professional with experience in investment banking and private equity (covering various sectors) in the US and Africa. Keen interest in high impact businesses. Co-founder and CFO of Yemaachi Biotech.

David Hutchful

Founder

I am passionate about designing and building tech solutions that are informed by a nuanced understanding of the socio-economic and cultural contexts of the problems. I've worked in the private (Microsoft Research) and non-profit (Grameen Foundation) sectors and built companies that use technology to improve peoples' lives. When I am not hacking ideas or technology, I love to read, travel and experience different cultures. I am always available to play or watch football.

LinkedIn · X